Form 4 for STRO SUTRO BIOPHARMA, INC.
Accepted 2021-09-28 00:00:00 ET · period of report 2021-09-24 · accession 0001209191-21-057982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-28 | 2021-09-28 | STRO | Vasquez Nicki | Chief Port. Strat, Alnce Ofcr | S - Sale+OE | $18.62 | -3,906 | 7,270 | -35% | -$72.7K |
| D | 2021-09-28 | 2021-09-24 | STRO | Vasquez Nicki | Chief Port. Strat, Alnce Ofcr | M - OptEx | $0.00 | +5,969 | 13.2K | +82% | $0 |
| D | 2021-09-28 | 2021-09-24 | STRO | Vasquez Nicki | Chief Port. Strat, Alnce Ofcr | F - Tax | $19.23 | -2,063 | 11.2K | -16% | -$39.7K |
| D | 2021-09-28 | 2021-09-24 | STRO | Vasquez Nicki | Chief Port. Strat, Alnce Ofcr | M - OptEx | $0.00 | -5,969 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-28 | S | D | 3,906 | $18.62 | 7,270 | D | — | — | (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.47 to $19.08 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-09-24 | M | A | 5,969 | $0.00 | 13,239 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-24 | F | D | 2,063 | $19.23 | 11,176 | D | — | — | (F1) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. |
| 4 | Derivative | Restricted Stock Unit (RSU) | 2021-09-24 | M | D | 5,969 | $0.00 | 0 | D | — · — to 2021-09-26 | 5,969 Common Stock | (F4) Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. (F5) The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. |